Investors are confident in Castle Biosciences' future growth...
Investors are confident in Castle Biosciences' future growth despite its high P/S ratio. The strong future revenue growth justifies the high P/S ratio, making a significant share price drop unlikely.
Investors Appear Satisfied With Castle Biosciences, Inc.'s (NASDAQ:CSTL) Prospects
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment